{"transactions":[{"id":4629021,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-02T21:47:56.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"In addition to the remaining options to purchase 10,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 92,320 shares of common stock, which options vest according to their terms."}],"balance_after":10000,"derivative":{"exercise_price":18.03,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001187333-26-000004","document":"form4-10022026_091051.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000118733326000004/form4-10022026_091051.xml","form_type":"4"}},{"id":4629020,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-02T21:47:56.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":49.8743,"value":249371.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 30, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.435 to $50.37 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":10995,"source":{"system":"sec-edgar","filing":"0001187333-26-000004","document":"form4-10022026_091051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000118733326000004/form4-10022026_091051.xml","form_type":"4"}},{"id":4629019,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-02T21:47:56.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":18.03,"value":90150.0,"ownership":{"direct":true},"balance_after":15995,"source":{"system":"sec-edgar","filing":"0001187333-26-000004","document":"form4-10022026_091051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000118733326000004/form4-10022026_091051.xml","form_type":"4"}},{"id":733736,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-06-17T20:05:15.000Z","date":"2026-06-15","kind":"exercise","planned":false,"acquired":false,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vests as to 100% of the total RSUs on June 15, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6030},"source":{"system":"sec-edgar","filing":"0001187333-26-000003","document":"form4-06172026_040606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000003/form4-06172026_040606.xml","form_type":"4"}},{"id":733735,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T20:05:15.000Z","date":"2026-06-15","kind":"exercise","planned":false,"acquired":true,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":10995,"source":{"system":"sec-edgar","filing":"0001187333-26-000003","document":"form4-06172026_040606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000003/form4-06172026_040606.xml","form_type":"4"}},{"id":802592,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":5500,"derivative":{"exercise_price":32.17,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802591,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":5500,"derivative":{"exercise_price":43.91,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802590,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":16510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":16510,"derivative":{"exercise_price":10.87,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":16510},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802589,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":16510,"derivative":{"exercise_price":14.83,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":16510},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802588,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":16510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":16510,"derivative":{"exercise_price":15.53,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":16510},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802587,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":16510,"derivative":{"exercise_price":21.19,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":16510},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802586,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":10600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":10600,"derivative":{"exercise_price":17.02,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":10600},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802585,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":10600,"derivative":{"exercise_price":23.23,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":10600},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802584,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":9200,"derivative":{"exercise_price":22.13,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":9200},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802583,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":9200,"derivative":{"exercise_price":30.44,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":9200},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802582,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":11000,"derivative":{"exercise_price":21.76,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802581,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":11000,"derivative":{"exercise_price":29.7,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802580,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":11000,"derivative":{"exercise_price":12.14,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802579,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":11000,"derivative":{"exercise_price":16.56,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802578,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":6000,"derivative":{"exercise_price":50.47,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802577,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":6000,"derivative":{"exercise_price":68.88,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802576,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":6000,"derivative":{"exercise_price":76.79,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802575,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":6000,"derivative":{"exercise_price":104.81,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802574,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":15000,"derivative":{"exercise_price":18.03,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":802573,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-22T22:34:31.000Z","date":"2026-04-20","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effective as of a pro rata distribution by AnaptysBio to holders of its shares of common stock pursuant to the Separation and Distribution Agreement dated as of April 20, 2026, by and between AnaptysBio and First Tracks (the \"Separation Agreement\"), each outstanding option to acquire AnaptysBio shares of common stock was adjusted so that such option became an option to acquire First Tracks shares of common stock and an option to acquire AnaptysBio shares of common stock. As a result, the Reporting Person acquired options to acquire AnaptyBio shares of common stock in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested and exercisable."}],"balance_after":15000,"derivative":{"exercise_price":24.6,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001187333-26-000002","document":"form4-04222026_100427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000002/form4-04222026_100427.xml","form_type":"4"}},{"id":943109,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-01-08T21:05:01.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":4000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001187333-26-000001","document":"form4-01082026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000001/form4-01082026_090157.xml","form_type":"4"}},{"id":943108,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-08T21:05:01.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":5500,"derivative":{"exercise_price":43.91,"expiration_date":"2036-01-05","underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0001187333-26-000001","document":"form4-01082026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000118733326000001/form4-01082026_090157.xml","form_type":"4"}},{"id":1068707,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T20:02:46.000Z","date":"2025-08-08","kind":"exercise","planned":true,"acquired":false,"shares":10231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option grant was issued on August 14, 2015, is fully vested and exercisable until its expiration date of August 13, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"In addition to the remaining options to purchase 10,231 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 101,820 shares of common stock, which options vest according to their terms."}],"balance_after":0,"derivative":{"exercise_price":6.93,"expiration_date":"2025-08-13","underlying":"Common Stock","underlying_shares":10231},"source":{"system":"sec-edgar","filing":"0001415889-25-021486","document":"form4-08122025_080842.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925021486/form4-08122025_080842.xml","form_type":"4"}},{"id":1068706,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T20:02:46.000Z","date":"2025-08-08","kind":"sale","planned":true,"acquired":false,"shares":7121,"price":19.696,"value":140255.216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options, including the options exercised and sold under this Form 4, which have an expiration date of August 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4965,"source":{"system":"sec-edgar","filing":"0001415889-25-021486","document":"form4-08122025_080842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925021486/form4-08122025_080842.xml","form_type":"4"}},{"id":1068705,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T20:02:46.000Z","date":"2025-08-08","kind":"sale","planned":true,"acquired":false,"shares":3110,"price":19.44,"value":60458.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options, including the options exercised and sold under this Form 4, which have an expiration date of August 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.375 to $19.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":12086,"source":{"system":"sec-edgar","filing":"0001415889-25-021486","document":"form4-08122025_080842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925021486/form4-08122025_080842.xml","form_type":"4"}},{"id":1068704,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T20:02:46.000Z","date":"2025-08-08","kind":"exercise","planned":true,"acquired":true,"shares":10231,"price":6.93,"value":70900.83,"ownership":{"direct":true},"balance_after":15196,"source":{"system":"sec-edgar","filing":"0001415889-25-021486","document":"form4-08122025_080842.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925021486/form4-08122025_080842.xml","form_type":"4"}},{"id":1092062,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-03T17:34:33.000Z","date":"2025-07-02","kind":"exercise","planned":true,"acquired":false,"shares":20925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"In addition to the remaining options to purchase 20,925 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 112,051 shares of common stock, which options vest according to their terms."}],"balance_after":0,"derivative":{"exercise_price":6.93,"expiration_date":"2025-07-05","underlying":"Common Stock","underlying_shares":20925},"source":{"system":"sec-edgar","filing":"0001415889-25-019242","document":"form4-07032025_050730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925019242/form4-07032025_050730.xml","form_type":"4"}},{"id":1092061,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-03T17:34:33.000Z","date":"2025-07-02","kind":"sale","planned":true,"acquired":false,"shares":13675,"price":23.8232,"value":325782.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options, including the options exercised and sold under this Form 4, which have an expiration date of July 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.56 to $24.015 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4965,"source":{"system":"sec-edgar","filing":"0001415889-25-019242","document":"form4-07032025_050730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925019242/form4-07032025_050730.xml","form_type":"4"}},{"id":1092060,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-03T17:34:33.000Z","date":"2025-07-02","kind":"sale","planned":true,"acquired":false,"shares":7250,"price":23.0908,"value":167408.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options, including the options exercised and sold under this Form 4, which have an expiration date of July 5, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.425 to $23.395 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18640,"source":{"system":"sec-edgar","filing":"0001415889-25-019242","document":"form4-07032025_050730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925019242/form4-07032025_050730.xml","form_type":"4"}},{"id":1092059,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-03T17:34:33.000Z","date":"2025-07-02","kind":"exercise","planned":true,"acquired":true,"shares":20925,"price":6.93,"value":145010.25,"ownership":{"direct":true},"balance_after":25890,"source":{"system":"sec-edgar","filing":"0001415889-25-019242","document":"form4-07032025_050730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925019242/form4-07032025_050730.xml","form_type":"4"}},{"id":1104816,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:06:46.000Z","date":"2025-06-18","kind":"sale","planned":true,"acquired":false,"shares":3015,"price":23.97,"value":72269.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024."},{"field":"shares","element":"transactionShares","label":"F2","text":"Shares sold to satisfy a portion of the tax obligation in connection with the vesting of restricted stock units on June 15, 2025."}],"balance_after":4965,"source":{"system":"sec-edgar","filing":"0001415889-25-017819","document":"form4-06202025_080641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925017819/form4-06202025_080641.xml","form_type":"4"}},{"id":1107713,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-06-17T22:30:48.000Z","date":"2025-06-15","kind":"exercise","planned":false,"acquired":false,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6030},"source":{"system":"sec-edgar","filing":"0001415889-25-017588","document":"form4-06172025_100644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925017588/form4-06172025_100644.xml","form_type":"4"}},{"id":1107712,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-17T22:30:48.000Z","date":"2025-06-15","kind":"exercise","planned":false,"acquired":true,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":7980,"source":{"system":"sec-edgar","filing":"0001415889-25-017588","document":"form4-06172025_100644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925017588/form4-06172025_100644.xml","form_type":"4"}},{"id":1307808,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-01-07T22:29:05.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2026 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":6030,"derivative":{"underlying":"Common Stock","underlying_shares":6030},"source":{"system":"sec-edgar","filing":"0001415889-25-001037","document":"form4-01072025_100100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925001037/form4-01072025_100100.xml","form_type":"4"}},{"id":1307807,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T22:29:05.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":16510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/12 of the total shares monthly commencing on Februray 7, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":16510,"derivative":{"exercise_price":14.83,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":16510},"source":{"system":"sec-edgar","filing":"0001415889-25-001037","document":"form4-01072025_100100.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588925001037/form4-01072025_100100.xml","form_type":"4"}},{"id":1344657,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T21:35:40.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 20,925 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 95,541 shares of common stock, which options vest according to their terms."}],"balance_after":20925,"derivative":{"exercise_price":6.93,"expiration_date":"2025-07-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-028094","document":"form4-12032024_091237.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924028094/form4-12032024_091237.xml","form_type":"4"}},{"id":1344656,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T21:35:40.000Z","date":"2024-11-29","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":25,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options before their expiration."}],"balance_after":1950,"source":{"system":"sec-edgar","filing":"0001415889-24-028094","document":"form4-12032024_091237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924028094/form4-12032024_091237.xml","form_type":"4"}},{"id":1344655,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-03T21:35:40.000Z","date":"2024-11-29","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":6.93,"value":69300.0,"ownership":{"direct":true},"balance_after":11950,"source":{"system":"sec-edgar","filing":"0001415889-24-028094","document":"form4-12032024_091237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924028094/form4-12032024_091237.xml","form_type":"4"}},{"id":1452392,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-17T20:45:35.000Z","date":"2024-07-15","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option grant was issued on July 6, 2015, is fully vested and exercisable until its expiration date of July 5, 2025."}],"balance_after":30925,"derivative":{"exercise_price":6.93,"expiration_date":"2025-07-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-019676","document":"form4-07172024_080731.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924019676/form4-07172024_080731.xml","form_type":"4"}},{"id":1452391,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-17T20:45:35.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":2897,"price":30.9817,"value":89753.9849,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options before their expiration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.92 to $31.27 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1950,"source":{"system":"sec-edgar","filing":"0001415889-24-019676","document":"form4-07172024_080731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924019676/form4-07172024_080731.xml","form_type":"4"}},{"id":1452390,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-17T20:45:35.000Z","date":"2024-07-15","kind":"sale","planned":true,"acquired":false,"shares":7103,"price":30.5038,"value":216668.4914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options before their expiration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.91 to $30.88 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4847,"source":{"system":"sec-edgar","filing":"0001415889-24-019676","document":"form4-07172024_080731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924019676/form4-07172024_080731.xml","form_type":"4"}},{"id":1452389,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-17T20:45:35.000Z","date":"2024-07-15","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":6.93,"value":69300.0,"ownership":{"direct":true},"balance_after":11950,"source":{"system":"sec-edgar","filing":"0001415889-24-019676","document":"form4-07172024_080731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924019676/form4-07172024_080731.xml","form_type":"4"}},{"id":1474944,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-19T00:15:03.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0001415889-24-017507","document":"form4-06192024_120659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924017507/form4-06192024_120659.xml","form_type":"4"}},{"id":1474943,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T00:15:03.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":1950,"price":23.16,"value":45162.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024"}],"balance_after":1950,"source":{"system":"sec-edgar","filing":"0001415889-24-017507","document":"form4-06192024_120659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924017507/form4-06192024_120659.xml","form_type":"4"}},{"id":1474942,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-19T00:15:03.000Z","date":"2024-06-15","kind":"exercise","planned":false,"acquired":true,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."}],"balance_after":3900,"source":{"system":"sec-edgar","filing":"0001415889-24-017507","document":"form4-06192024_120659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000141588924017507/form4-06192024_120659.xml","form_type":"4"}},{"id":1685339,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-01-05T21:56:29.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":6030,"derivative":{"underlying":"Common Stock","underlying_shares":6030},"source":{"system":"sec-edgar","filing":"0001209191-24-001048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919124001048/doc4.xml","form_type":"4"}},{"id":1685338,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-05T21:56:29.000Z","date":"2024-01-03","kind":"grant","planned":false,"acquired":true,"shares":16510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/12 of the total shares monthly commencing on Februray 3, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":16510,"derivative":{"exercise_price":21.19,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":16510},"source":{"system":"sec-edgar","filing":"0001209191-24-001048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919124001048/doc4.xml","form_type":"4"}},{"id":1717655,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-08T22:41:20.000Z","date":"2023-12-07","kind":"grant","planned":false,"acquired":true,"shares":37000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 7, 2023."}],"balance_after":37000,"derivative":{"exercise_price":9.55,"expiration_date":"2033-12-06","underlying":"Common Stock","underlying_shares":37000},"source":{"system":"sec-edgar","filing":"0000950170-23-069121","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000095017023069121/ownership.xml","form_type":"4"}},{"id":2057366,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-01-11T00:10:40.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock award (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":3900,"derivative":{"underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0001209191-23-002884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919123002884/doc4.xml","form_type":"4"}},{"id":2057365,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-11T00:10:40.000Z","date":"2023-01-06","kind":"grant","acquired":true,"shares":10600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":10600,"derivative":{"exercise_price":23.23,"expiration_date":"2033-01-05","underlying":"Common Stock","underlying_shares":10600},"source":{"system":"sec-edgar","filing":"0001209191-23-002884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919123002884/doc4.xml","form_type":"4"}},{"id":2076657,"issuer":{"id":4458,"kind":"organization","name":"Zymeworks Inc.","symbol":"ZYME"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-24T00:00:14.000Z","date":"2022-12-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of December 21, 2022."}],"balance_after":25000,"derivative":{"exercise_price":8.75,"expiration_date":"2032-12-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-22-039321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000089924322039321/doc4.xml","form_type":"4"}},{"id":2397530,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-14T21:48:22.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":9200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":9200,"derivative":{"exercise_price":30.44,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":9200},"source":{"system":"sec-edgar","filing":"0001209191-22-009339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919122009339/doc4.xml","form_type":"4"}},{"id":2722921,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-07T20:45:16.000Z","date":"2021-05-06","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 6, 2021."}],"balance_after":9000,"derivative":{"exercise_price":29.49,"expiration_date":"2031-05-05","underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-21-018763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924321018763/doc4.xml","form_type":"4"}},{"id":2862747,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-13T02:44:00.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/12 of the total shares monthly beginning on March 10, 2021 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":11000,"derivative":{"exercise_price":29.7,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-21-010534","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919121010534/doc4.xml","form_type":"4"}},{"id":3091375,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:38:51.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":59092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"In connection with the Merger, these options were accelerated and canceled without payment."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":59092},"source":{"system":"sec-edgar","filing":"0001209191-20-040364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040364/doc4.xml","form_type":"4"}},{"id":3091374,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-02T16:38:51.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":11377,"price":0.06,"value":682.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, each of these unvested and outstanding options was accelerated, canceled and converted into the right to receive a cash amount equal to the product of (i) the number of shares that are subject to such options and (ii) $18.00 less the applicable exercise price per share of such options, subject to any applicable withholding or other taxes required by applicable law."}],"balance_after":0,"derivative":{"exercise_price":17.94,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":11377},"source":{"system":"sec-edgar","filing":"0001209191-20-040364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040364/doc4.xml","form_type":"4"}},{"id":3091373,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-07-02T16:38:51.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":7281,"price":18,"value":131058.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"At the Effective Time, each restricted stock unit (\"RSU\") was accelerated and canceled as of immediately prior to, and contingent upon, the Effective Time, in exchange for the right to receive a cash amount equal to the product of (i) the number of shares deliverable under such RSU multiplied by (ii) $18.00."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-040364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040364/doc4.xml","form_type":"4"}},{"id":3091372,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T16:38:51.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":2826,"price":18,"value":50868.0,"ownership":{"direct":false,"nature":"The Renton Family Community Property Trust"},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc. (the \"Issuer\"), Alexion\nPharmaceuticals, Inc. (\"Alexion\") and Odyssey Merger Sub Inc. (\"Merger Sub\") (the \"Merger Agreement\"), on July 2, 2020, Merger Sub merged with and\ninto the Issuer, with the Issuer continuing as the surviving corporation and a direct, wholly owned subsidiary of Alexion (the \"Merger\"). At the\neffective time of the Merger (the \"Effective Time\"), these shares were canceled in exchange for $18.00 per share in cash, without interest and\nsubject to any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-040364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040364/doc4.xml","form_type":"4"}},{"id":3091371,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T16:38:51.000Z","date":"2020-07-02","kind":"disposition_to_issuer","acquired":false,"shares":13194,"price":18,"value":237492.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 5, 2020, by and among Portola Pharmaceuticals, Inc. (the \"Issuer\"), Alexion\nPharmaceuticals, Inc. (\"Alexion\") and Odyssey Merger Sub Inc. (\"Merger Sub\") (the \"Merger Agreement\"), on July 2, 2020, Merger Sub merged with and\ninto the Issuer, with the Issuer continuing as the surviving corporation and a direct, wholly owned subsidiary of Alexion (the \"Merger\"). At the\neffective time of the Merger (the \"Effective Time\"), these shares were canceled in exchange for $18.00 per share in cash, without interest and\nsubject to any applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-040364","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120040364/doc4.xml","form_type":"4"}},{"id":3110382,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-15T19:10:50.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":11377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest on the first of each month after the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":11377,"derivative":{"exercise_price":17.94,"expiration_date":"2030-06-11","underlying":"Common Stock","underlying_shares":11377},"source":{"system":"sec-edgar","filing":"0001209191-20-036781","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120036781/doc4.xml","form_type":"4"}},{"id":3110381,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T19:10:50.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":7281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSUs\") in consideration of services rendered. The RSUs fully vest on March 1, 2021, subject to the Reporting Person's Continuous Services (as defined in the Issuer's 2013 Equity Incentive Plan) as of such date."}],"balance_after":20475,"source":{"system":"sec-edgar","filing":"0001209191-20-036781","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919120036781/doc4.xml","form_type":"4"}},{"id":3152530,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-12T06:30:24.000Z","date":"2020-05-08","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 8, 2020."}],"balance_after":9000,"derivative":{"exercise_price":35.49,"expiration_date":"2030-05-07","underlying":"Common Shares","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-20-012773","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924320012773/doc4.xml","form_type":"4"}},{"id":3273674,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-02-13T22:07:51.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 12, 2020, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":11000,"derivative":{"exercise_price":16.56,"expiration_date":"2030-02-11","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-20-009322","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919120009322/doc4.xml","form_type":"4"}},{"id":3382032,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-11-04T19:32:28.000Z","date":"2019-11-01","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 20,000 shares, became exercisable monthly over a two year period beginning on May 29, 2010."}],"balance_after":5000,"derivative":{"exercise_price":9,"expiration_date":"2020-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-055045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119055045/doc4.xml","form_type":"4"}},{"id":3382031,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-04T19:32:28.000Z","date":"2019-11-01","kind":"sale","acquired":false,"shares":5000,"price":30,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2019."}],"balance_after":13194,"source":{"system":"sec-edgar","filing":"0001209191-19-055045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119055045/doc4.xml","form_type":"4"}},{"id":3382030,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-04T19:32:28.000Z","date":"2019-11-01","kind":"exercise","acquired":true,"shares":5000,"price":9,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2019."}],"balance_after":18194,"source":{"system":"sec-edgar","filing":"0001209191-19-055045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119055045/doc4.xml","form_type":"4"}},{"id":3442240,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-08-09T18:51:05.000Z","date":"2019-08-08","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 20,000 shares, became exercisable monthly over a two year period beginning on May 29, 2010."}],"balance_after":10000,"derivative":{"exercise_price":9,"expiration_date":"2020-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-045396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119045396/doc4.xml","form_type":"4"}},{"id":3442239,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-09T18:51:05.000Z","date":"2019-08-08","kind":"sale","acquired":false,"shares":5000,"price":30,"value":150000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019."}],"balance_after":13194,"source":{"system":"sec-edgar","filing":"0001209191-19-045396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119045396/doc4.xml","form_type":"4"}},{"id":3442238,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-08-09T18:51:05.000Z","date":"2019-08-08","kind":"exercise","acquired":true,"shares":5000,"price":9,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019."}],"balance_after":18194,"source":{"system":"sec-edgar","filing":"0001209191-19-045396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119045396/doc4.xml","form_type":"4"}},{"id":3487527,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-17T17:33:15.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":6991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest on the first of each month after the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":6991,"derivative":{"exercise_price":26.09,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":6991},"source":{"system":"sec-edgar","filing":"0001209191-19-037464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119037464/doc4.xml","form_type":"4"}},{"id":3487526,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-17T17:33:15.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":4194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSUs\") in consideration of services rendered. The RSUs fully vest on March 1, 2020, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of such date."}],"balance_after":13194,"source":{"system":"sec-edgar","filing":"0001209191-19-037464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119037464/doc4.xml","form_type":"4"}},{"id":3535019,"issuer":{"id":12038,"kind":"organization","name":"Zymeworks BC Inc.","symbol":"ZYME"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-08T16:21:16.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock options vest on date of next annual general meeting following grant date of May 6, 2019."}],"balance_after":10000,"derivative":{"exercise_price":19.11,"expiration_date":"2029-05-05","underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000899243-19-012636","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1403752/000089924319012636/doc4.xml","form_type":"4"}},{"id":3554967,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-04-16T19:44:16.000Z","date":"2019-04-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing a right to purchase a total of 20,000 shares, became exercisable monthly over a two year period beginning on May 29, 2010."}],"balance_after":15000,"derivative":{"exercise_price":9,"expiration_date":"2020-04-27","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-024839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119024839/doc4.xml","form_type":"4"}},{"id":3554966,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-16T19:44:16.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":400,"price":35.0675,"value":14027.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.0000 to $35.1800, inclusive. The reporting person undertakes to provide Portola Pharmaceuticals, Inc., any security holder of Portola Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) - (3) to this Form 4."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-19-024839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119024839/doc4.xml","form_type":"4"}},{"id":3554965,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-16T19:44:16.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":4600,"price":34.3962,"value":158222.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.9700 to $34.9650, inclusive. The reporting person undertakes to provide Portola Pharmaceuticals, Inc., any security holder of Portola Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) - (3) to this Form 4."}],"balance_after":9400,"source":{"system":"sec-edgar","filing":"0001209191-19-024839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119024839/doc4.xml","form_type":"4"}},{"id":3554964,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-16T19:44:16.000Z","date":"2019-04-15","kind":"exercise","acquired":true,"shares":5000,"price":9,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2019."}],"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001209191-19-024839","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919119024839/doc4.xml","form_type":"4"}},{"id":3665579,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-02-11T22:34:41.000Z","date":"2019-02-08","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 8, 2019, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":6000,"derivative":{"exercise_price":68.89,"expiration_date":"2019-02-07","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-19-009036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919119009036/doc4.xml","form_type":"4"}},{"id":3899797,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-08T18:42:10.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest on the first of each month after the grant date, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":6000,"derivative":{"exercise_price":42.81,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-18-036778","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919118036778/doc4.xml","form_type":"4"}},{"id":3899796,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T18:42:10.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSU\") in consideration of services rendered. The RSUs fully vest on March 1, 2019, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of such date."}],"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-18-036778","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919118036778/doc4.xml","form_type":"4"}},{"id":4073511,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2018-02-06T21:13:55.000Z","date":"2018-02-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 12 equal monthly installments beginning on March 2, 2018, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":6000,"derivative":{"exercise_price":104.81,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-18-007832","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919118007832/doc4.xml","form_type":"4"}},{"id":4277277,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-19T18:14:01.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option shall vest as follows: 1/12th of the shares subject to the option shall vest each month after June 1, 2017, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2013 Equity Incentive Plan) as of each such date."}],"balance_after":6000,"derivative":{"exercise_price":35.06,"expiration_date":"2027-06-16","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-040923","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919117040923/doc4.xml","form_type":"4"}},{"id":4277276,"issuer":{"id":147987,"kind":"organization","name":"PORTOLA PHARMACEUTICALS INC","symbol":"PTLA"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-19T18:14:01.000Z","date":"2017-06-16","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of Restricted Stock Units (\"RSU\") in consideration of services rendered. The RSUs fully vest on March 1, 2018, subject to Reporting Person's Continuous Service as of each such date."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-17-040923","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1269021/000120919117040923/doc4.xml","form_type":"4"}},{"id":4417105,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2017-02-28T23:55:53.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes fully exercisable on February 24, 2018."}],"balance_after":15000,"derivative":{"exercise_price":24.6,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-015461","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1187333/000120919117015461/doc4.xml","form_type":"4"}},{"id":4565562,"issuer":{"id":181259,"kind":"organization","name":"CEPHEID","symbol":"CPHD"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2016-11-07T19:37:30.000Z","date":"2016-11-04","kind":"disposition_to_issuer","acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Upon the Closing, 100% of this option's vesting was accelerated and converted into the right to receive an amount of cash equal to the number of shares outstanding under the option multiplied by $53.00 minus the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the grant vested and became exercisable on the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":36.59,"expiration_date":"2023-04-26","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001209191-16-148750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1037760/000120919116148750/doc4.xml","form_type":"4"}},{"id":4565561,"issuer":{"id":181259,"kind":"organization","name":"CEPHEID","symbol":"CPHD"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2016-11-07T19:37:30.000Z","date":"2016-11-04","kind":"disposition_to_issuer","acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Upon the Closing, this option was cancelled and ceased to exist without receiving any payment therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the grant vested and became exercisable on the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":56.7,"expiration_date":"2022-04-28","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001209191-16-148750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1037760/000120919116148750/doc4.xml","form_type":"4"}},{"id":4565560,"issuer":{"id":181259,"kind":"organization","name":"CEPHEID","symbol":"CPHD"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2016-11-07T19:37:30.000Z","date":"2016-11-04","kind":"disposition_to_issuer","acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the grant vested and became exercisable on the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":45.59,"expiration_date":"2021-04-22","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001209191-16-148750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1037760/000120919116148750/doc4.xml","form_type":"4"}},{"id":4565559,"issuer":{"id":181259,"kind":"organization","name":"CEPHEID","symbol":"CPHD"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2016-11-07T19:37:30.000Z","date":"2016-11-04","kind":"disposition_to_issuer","acquired":false,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the grant vested and became exercisable on the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":38.13,"expiration_date":"2020-04-30","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-16-148750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1037760/000120919116148750/doc4.xml","form_type":"4"}},{"id":4565558,"issuer":{"id":181259,"kind":"organization","name":"CEPHEID","symbol":"CPHD"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2016-11-07T19:37:30.000Z","date":"2016-11-04","kind":"disposition_to_issuer","acquired":false,"shares":7800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the grant vested and became exercisable on the one-year anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":35.72,"expiration_date":"2019-04-24","underlying":"Common Stock","underlying_shares":7800},"source":{"system":"sec-edgar","filing":"0001209191-16-148750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1037760/000120919116148750/doc4.xml","form_type":"4"}},{"id":4565557,"issuer":{"id":181259,"kind":"organization","name":"CEPHEID","symbol":"CPHD"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-07T19:37:30.000Z","date":"2016-11-04","kind":"disposition_to_issuer","acquired":false,"shares":11567,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number includes RSUs previously reported on Table I that at closing, were accelerated and converted into the right to receive $53 per share, without interest."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On September 2, 2016, the Issuer entered into an Agreement and Plan of Merger (\"Merger Agreement\") with Danaher Corporation, a Delaware corporation (the \"Acquirer\"), and Copper Merger Sub, Inc., a California corporation and a wholly-owned subsidiary of the Acquirer.  Upon the closing of the transactions contemplated by the Merger Agreement on November 4, 2016 (the \"Closing\"), each of the Reporting Person's shares of the Issuer's Common Stock was cancelled and converted into the right to receive $53.00, without interest (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-16-148750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1037760/000120919116148750/doc4.xml","form_type":"4"}},{"id":4565556,"issuer":{"id":181259,"kind":"organization","name":"CEPHEID","symbol":"CPHD"},"owners":[{"id":37184,"kind":"person","name":"RENTON HOLLINGS","position":1,"cik":"0001187333","reported_name":"RENTON HOLLINGS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-07T19:37:30.000Z","date":"2016-10-31","kind":"gift","acquired":false,"shares":3350,"price":52.9,"value":177215.0,"ownership":{"direct":true},"balance_after":11567,"source":{"system":"sec-edgar","filing":"0001209191-16-148750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1037760/000120919116148750/doc4.xml","form_type":"4"}}]}